REG - JPMorgan Claver IT - Ten Largest Investments

Jpmorgan Claverhouse Investment TrustAnnouncement

11/03/2025 12:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250311:nRSK2205Aa&default-theme=true

RNS Number : 2205A  JPMorgan Claverhouse IT PLC  11 March 2025
 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC  (the 'Company')
 Legal Entity Identifier: 549300NFZYYFSCD52W53
 THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at:
 28 February 2025
 Hsbc Holdings Plc                                                              8.1%
 Shell Plc                                                                      7.5%
 Astrazeneca Group Plc                                                          5.6%
 3I Group Plc                                                                   3.8%
 Bp Plc                                                                         3.2%
 Natwest Group Plc                                                              3.2%
 Unilever Plc                                                                   3.2%
 Relx Plc                                                                       3.1%
 Barclays Plc                                                                   3.1%
 Rolls-Royce Plc                                                                3.0%
 Total                                                                          43.8%
 Excludes Investments in Liquidity stocks
 Name of contact and telephone number for queries:
 Paul Ainger 0044 207 742 6524
 Name of authorised company official responsible for making this notification:
 Anmol Dhillon 020 7742 4000 - Company Secretary
 Date: 11 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFUUARURVVUOAAR